Interpretation of IST and CAST stroke trials. International Stroke Trial. Chinese Acute Stroke Trial.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  The Lancet

• Publication date

  1997-08-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(05)64161-XPMID 9259672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Highly Variable Anticoagulant Response After Subcutaneous Administration of High‐Dose (12,500 IU) Heparin in Patients With Myocardial Infarction and Healthy Volunteers

  1992cited by this paper

• Effects of ezetimibe and anticoagulant combined therapy on progressing stroke: a randomized, placebo-controlled study

  2016cites this paper
• Consensus Statement on Diagnosis and Treatment of Acute Ischemic Stroke Stroke Council-Argentine Society of Cardiology

  2012cites this paper
• Anticoagulation Therapy in ICU Patients

  2012cites this paper
• Planning a clinical research study

  2007cites this paper
• Neurologische Komplikationen renaler Erkrankungen

  2003cites this paper
• Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use

  2003cites this paper
• Anticoagulation for Acute Ischaemic Stroke?

  2001cites this paper
• Trends in Acute Ischemic Stroke Trials Through the 20th Century

  2001cites this paper
• Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.

  2000cites this paper
• Section Editor: Considering the Role of Heparin and Low-molecular-weight Heparins in Acute Ischemic Stroke

  year unknowncites this paper
• Analysis of prognostic factors and construction of a risk model for patients with acute cerebral infarction treated with dual antiplatelet therapy after optimal hyper thrombolytic time window.

  year unknowncites this paper